Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy

Journal of Biochemistry

Volumn 138, Issue 5, 2005, Pages 571-582

  Nakayama, Daisuke ^a   Misumi, Shogo ^a   Mukai, Ryouzaburo ^b   Tachibana, Kuniomi ^c   Umeda, Mamoru ^c   Shibata, Hideaki ^c   Takamune, Nobutoki ^a   Shoji, Shozo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c Central Research Laboratory of Nissui Pharmaceutical Co Ltd   (Japan)

Author keywords

AIDS; Autoantibody; Chemokine receptor; HIV; Vaccine

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIGEN; ASPARTIC ACID; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; CHIMERIC DODECAPEPTIDE; CHIMERIC PROTEIN; FREUND ADJUVANT; GLYCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MONOCLONAL ANTIBODY; MULTIPLE ANTIGEN PEPTIDE; PENTAPEPTIDE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONJUGATION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IN VITRO STUDY; MONKEY; NONHUMAN; PROTEIN CONFORMATION; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS STRAIN;

AIDS VACCINES; ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; MACACA FASCICULARIS; MICE; MICE, INBRED BALB C; PEPTIDES; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; RECEPTORS, CCR5; RECEPTORS, CXCR4; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA FASCICULARIS;

EID: 30344469034     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvi165     Document Type: Article

References (40)

1. Feng, Y., Broder, C.C., Kennedy, P.E., and Berger, E.A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877
2. Berger, E.A., Doms, R.W., Fenyo, E.M., Korber, B.T., Littman, D.R., Moore, J.P., Sattentau, Q.J., Schuitemaker, H., Sodroski, J., and Weiss, R.A. (1998) A new classification for HIV-1. Nature 391, 240
3. Berger, E.A., Murphy, P.M., and Farber, J.M. (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17, 657-700
4. Littman, D.R. (1998) Chemokine receptors: keys to AIDS pathogenesis? Cell 93, 677-680
5. Connor, R.I., Sheridan, K.E., Ceradini, D., Choe, S., and Landau, N.R. (1997) Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185, 621-628
6. Richman, D.D., Wrin, T., Little, S.J., and Petropoulos, C.J. (2003) Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 100, 4144-4149
7. Goulder, P.J., Phillips, R.E., Colbert, R.A., McAdam, S., Ogg, G., Nowak, M.A., Giangrande, P., Luzzi, G., Morgan, B., Edwards, A., McMichael, A.J., and Rowland-Jones, S. (1997) Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3, 212-217
8. Barouch, D.H., Kunstman, J., Kuroda, M.J., Schmitz, J.E., Santra, S., Peyerl, F.W., Krivulka, G.R., Beaudry, K., Lifton, M.A., Gorgone, D.A., Montefiori, D.C., Lewis, M.G., Wolinsky, S.M., and Letvin, N.L. (2002) Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature 415, 335-339
9. Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B.H., Bhattacharya, T., and Korber, B. (2003) Diversity considerations in HIV-1 vaccine selection. Science 296, 2354-2360
10. Novitsky, V., Smith, U.R., Gilbert, P., McLane, M.F., Chigwedere, P., Williamson, C., Ndung'u, T., Klein, I., Chang, S.Y., Peter, T., Thior, I., Foley, B.T., Gaolekwe, S., Rybak, N., Gaseitsiwe, S., Vannberg, F., Marlink, R., Lee, T.H., and Essex, M. (2002) Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J. Virol. 76, 5435-51
11. Misumi, S., Takamune, N., Ido, Y., Hayashi, S., Endo, M., Mukai, R., Tachibana, K., Umeda, M., and Shoji, S. (2001) Evidence as a HIV-1 self-defense vaccine of cyclic chimeric dodecapeptide warped from undecapeptidyl arch of extracellular loop 2 in both CCR5 and CXCR4. Biochem. Biophys. Res. Commun. 285, 1309-1316
12. Misumi, S., Nakajima, R., Takamune, N., and Shoji, S. (2001) A cyclic dodecapeptide-multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg(168) to Cys(178)) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine. J. Virol. 75, 11614-11620
13. Misumi, S., Endo, M., Mukai, R., Tachibana, K., Umeda, M., Honda, T., Takamune, N., and Shoji, S. (2003) A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progression. J. Biol. Chem. 278, 32335-32343
14. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R.J., Collman, R.G., Doms, R.W., Vassart, G., and Parmentier, M. (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725
15. Lopalco, L., Barassi, C., Pastori, C., Longhi, R., Burastero, S.E., Tambussi, G., Mazzotta, F., Lazzarin, A., Clerici, M., and Siccardi, A.G. (2000) CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro. J. Immunol. 164, 3426-3433
16. Stewart, G. (1998) Chemokine genes - beating the odds. Nat. Med. 4, 275-277
17. Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I., and Littman, D.R. (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599
18. Doranz, B.J., Filion, L.G., Diaz-Mitoma, F., Sitar, D.S., Sahai, J., Baribaud, F., Orsini, M.J., Benovic, J.L., Cameron, W., and Doms, R.W. (2001) Safe use of the CXCR4 inhibitor ALX40-4C in humans. AIDS Res. Hum. Retroviruses 17, 475-486
19. Hendrix, C.W., Flexner, C., MacFarland, R.T., Giandomenico, C., Fuchs, E.J., Redpath, E., Bridger, G., and Henson, G.W. (2000) Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob. Agents Chemother. 44, 1667-1673
20. Este, J.A., Cabrera, C., Blanco, J., Gutierrez, A., Bridger, G., Henson, G., Clotet, B., Schols, D., and De, C.E., (1999) Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4. J. Virol. 73, 5577-5585
21. Rusconi, S., La, S.C.S., Citterio, P., Bulgheroni, E., Croce, F., Herrmann, S.H., Offord, R.E., Galli, M., and Hirsch, M.S. (2000) Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections. J. Virol. 74, 9328-9332
22. Lee, B., Sharron, M., Blanpain, C., Doranz, B.J., Vakili, J., Setoh, P., Berg, E., Liu, G., Guy, H.R., Durell, S.R., Parmentier, M., Chang, C.N., Price, K., Tsang, M., and Doms, R.W. (1999) Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J. Biol. Chem. 274, 9617-9626
23. Kajumo, F., Thompson, D.A., Guo, Y., and Dragic, T. (2000) Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop of CXCR4. Virology 271, 240-247
24. Harouse, J.M., Gettie, A., Tan, R.C., Blanchard, J., and Cheng-Mayer, C. (1999) Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284, 816-819
25. Joag, S.V., Li, Z., Foresman, L., Stephens, E.B., Zhao, L.J., Adany, I., Pinson, D.M., McClure, H.M., and Narayan, O. (1996) Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J. Virol. 70, 3189-3197
26. Soda, Y., Shimizu, N., Jinno, A., Liu, H.Y., Kanbe, K., Kitamura, T., and Hoshino, H. (1999) Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line. Biochem. Biophys. Res. Commun. 258, 313-321
27. Hachiya, A., Aizawa-Matsuoka, S., Tanaka, M., Takahashi, Y., Ida, S., Gatanaga, H., Hirabayashi, Y., Kojima, A., Tatsumi, M., and Oka, S. (2001) Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5). Antimicrob. Agents Chemother. 45, 495-501
28. Gosling, J., Monteclaro, F.S., Atchison, R.E., Arai, H., Tsou, C.L., Goldsmith, M.A., and Charo, I.F. (1997) Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94, 5061-5066
29. Ditzel, H.J., Rosenkilde, M.M., Garred, P., Wang, M., Koefoed, K., Pedersen, C., Burton, D.R., and Schwartz, T.W. (1998) The CCR5 receptor acts as an alloantigen in CCR5Delta32 homozygous individuals: identification of chemokine and HIV-1-blocking human antibodies. Proc. Natl. Acad. Sci. USA 95, 5241-5245
30. Bouhlal, H., Hocini, H., Quillent-Gregoire, C., Donkova, V., Rose, S., Amara, A., Longhi, R., Haeffner-Cavaillon, N., Beretta, A., Kaveri, S.V., and Kazatchkine, M.D. (2001) Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1. J. Immunol. 166, 7606-7611
31. Wang, Y., Underwood, J., Vaughan, R., Harmer, A., Doyle, C., and Lehner, T. (2002) Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women. Clin. Exp. Immunol. 129, 493-501
32. Lehner, T., Wang, Y., Doyle, C., Tao, L., Bergmeier, L.A., Mitchell, E., Bogers, W.M., Heeney, J., and Kelly, C.G. (1999) Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques. Eur. J. Immunol. 29, 2427-2435
33. Zuber, B., Hinkula, J., Vodros, D., Lundholm, P., Nilsson, C., Morner, A., Levi, M., Benthin, R., and Wahren, B. (2000) Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge. Virology 278, 400-411
34. Bogers, W.M., Bergmeier, L.A., Oostermeijer, H., ten Haaft, P., Wang, Y., Kelly, C.G., Singh, M., Heeney, J.L., and Lehner, T. (2004) CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection. Vaccine 22, 2974-2984
35. Chackerian, B., Briglio, L., Albert, P.S., Lowy, D.R., and Schiller, J.T. (2004) Induction of autoantibodies to CCR5 in macaques and subsequent effects upon challenge with an R5-tropic simian/human immunodeficiency virus. J. Virol. 78, 4037-4047
36. Bogers, W.M., Bergmeier, L.A., Ma, J., Oostermeijer, H., Wang, Y., Kelly, C.G., Ten Haaft, P., Singh, M., Heeney, J.L., and Lehner, T. (2004) A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS 18, 25-36
37. Blanpain, C., Vanderwinden, J.M., Cihak, J., Wittamer, V., Le Poul, E., Issafras, H., Stangassinger, M., Vassart, G., Marullo, S., Schlndorff, D., Parmentier, M., and Mack, M. (2002) Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol. Biol. Cell 13, 723-737
38. Baribaud, F., Edwards, T.G., Sharron, M., Brelot, A., Heveker, N., Price, K., Mortari, F., Alizon, M., Tsang, M., and Doms, R.W. (2001) Antigenically distinct conformations of CXCR4. J. Virol. 75, 8957-8967
39. James, L.C., Roversi, P., and Tawfik, D.S. (2003) Antibody multispecificity mediated by conformational diversity. Science 299, 1362-1367
40. Thompson, D.A., Cormier, E.G., and Dragic, T. (2002) CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates. J. Virol. 76, 3059-3064